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of working through the experiences of patients from their per-
spective and reappraising them (Kuipers et al., 2006; Garety 
et al., 2007).
Consistent with the notion of additional benefi ts of CBTp 
to pharmacotherapy alone, a large number of randomised con-
trolled trials (RCTs) have demonstrated that persistent positive 
symptoms, particularly delusions, and general symptoms, such as 
anxiety and depression, are improved by CBTp in patients who fail 
to show adequate clinical response to antipsychotic therapy alone 
(Pilling et al., 2002; Zimmermann et al., 2005; Pfammatter et al., 
2006; Wykes et al., 2008). The National Institute for Health and 
Clinical Excellence (NICE) updated guidelines for schizophrenia 
in the UK (NICE, 2009) recommend that CBTp should be offered 
as well as pharmacotherapy to all individuals with psychosis who 
request it. A meaningful clinical response to CBTp, however, is 
seen in only about 50% of patients who receive it (Pfammatter 
et al., 2006; Wykes et al., 2008). A greater understanding of the 
mediators of CBTp response may help to increase its benefi ts for 
the patients.
INTRODUCTION
The benefi cial effects of antipsychotics on positive symptoms in 
acutely ill patients with schizophrenia (Kasper, 2006), most likely 
via their actions at dopamine receptors (Kapur and Remington, 
2001; Guillin et al., 2007), are well established. The long-term out-
come for up to 40% of patients, however, remains unsatisfactory as 
they continue to suffer from one or more distressing symptoms of 
schizophrenia despite remaining compliant with their prescribed 
medication (Conley and Kelly, 2001; McEvoy et al., 2007; Potkin 
et al., 2009).
Kapur (2003) proposed that antipsychotics only “dampen the 
salience” of the abnormal experiences that cause or contribute 
to formation of psychotic symptoms (e.g. delusions) but do 
not “erase” the symptoms; symptom elimination or improve-
ment in the longer run requires the patients to “work through” 
and reappraise their experiences. Embedded within the basic 
 principles of most psychological interventions for psychiatric 
disorders, including cognitive behaviour therapy for psychosis 
(CBTp) (Fowler et al., 1995; Garety et al., 2007), is the  process 
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Despite the favourable effects of antipsychotics on positive symptoms of schizophrenia, many 
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fi ndings implicate language processing (IFG), attention (thalamus), insight and self-awareness 
(medial prefrontal and parietal cortices) in CBTp responsiveness in schizophrenia.
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There are few published data on predictors of response to CBTp 
in schizophrenia. At the neuropsychological level, cognitive fl ex-
ibility is found to predict the effect of CBTp on delusional think-
ing (Garety et al., 1997). Clinically, cognitive insight has emerged 
as a potential mediator of CBTp responsiveness (Granholm et al., 
2006). At the neural level, greater pre-therapy brain activity in the 
dorsolateral prefrontal cortex (DLPFC) and its connectivity with the 
cerebellum during a spatial (dot-back) working memory task has 
been shown to be associated with greater responsiveness to CBTp 
in schizophrenia, most likely via the DLPFC-cerebellum contribu-
tions to executive processing (Kumari et al., 2009). Interestingly, the 
association between CBTp responsiveness and greater pre-therapy 
DLPFC activity in this study was particularly strong for the left hemi-
sphere, suggesting that the left-hemisphere function may be more 
pertinent to CBTp (Kumari et al., 2009). Greater left-hemisphere 
advantage for verbal processing has also been associated with a more 
favorable outcome of CBT for depression (Bruder et al., 1997). Given 
the possible link between schizophrenia and language pathway 
abnormalities (Crow, 2000; Li et al., 2009), the association between 
left-hemisphere based language processes and CBTp responsiveness 
may be particularly salient in this clinical population.
The present study aimed to examine the neural predictors of 
responsiveness to CBTp in schizophrenia using functional magnetic 
resonance imaging (fMRI) during a task involving monitoring of self- 
and externally-generated speech (Johns et al., 2001; Fu et al., 2006; 
Kumari et al., 2008). Accurate performance on this task produces 
activity changes in a neural network comprised of inferior frontal, cin-
gulate, lateral temporal, inferior parietal, putamen and thalamic brain 
areas both in healthy people and patients with schizophrenia (Kumari 
et al., 2008). The main hypothesis, based on fi ndings of previous stud-
ies concerning neural predictors of CBT (Bruder et al., 1997; Kumari 
et al., 2009), was that pre-therapy activation level of the left inferior 
frontal gyrus (IFG), which is known to be involved in language pro-
duction (Demonet et al., 2005; Binder et al., 2009) and perception of 
self- and other-generated speech (Raveendran and Kumari, 2007), will 
be predictive of responsiveness to CBTp in schizophrenia. In addition, 
we expected task-related activity changes in the inferior parietal cor-
tex since this brain region has been proposed (Shad et al., 2007) and 
empirically found to be associated with insight (specifi cally, awareness 
of problems) in psychosis (Cooke et al., 2008). We, however, explored 
task-related activations and deactivations across the entire brain as 
predictors of responsiveness to CBTp, given the dearth of studies on 
prediction of response to CBTp, as well on the brain basis of cognitive 
insight. Cognitive insight, unlike clinical insight, also encompasses the 
evaluation and correction of distorted beliefs and misinterpretations 
(Beck et al., 2004) and has been shown to mediate responsiveness to 
CBT in schizophrenia (Granholm et al., 2006). Furthermore, we also 
studied a group of healthy participants, matched on average to age 
and sex of the patient group, to investigate whether specifi c activity 
changes (if found) associated with CBTp responsiveness represented 
hyper-, hypo-, or normal level of activity changes.
MATERIALS AND METHODS
PARTICIPANTS AND DESIGN
The study involved 56 outpatients with schizophrenia diagnosed 
using DSM-IV structured clinical interview (SCID) (First et al., 
1995), 26 of whom received CBTp for 6–8 months in addition to 
their treatment-as-usual (CBTp + TAU group) while 26 contin-
ued to receive their usual treatment (TAU-alone group). A group 
of 20 healthy participants screened for a history of mental illness 
using SCID-I NP (First et al., 2002) and matched, on average, to 
patients on age and sex, were studied for comparison purposes. This 
investigation has been carried out as part of a larger project exam-
ining neural predictors and correlates of responsiveness to CBTp 
in schizophrenia. The sample of patients and healthy participants 
included in this report thus overlaps with the sample examined in 
our recent report (Kumari et al., 2009) on neural responsiveness of 
CBTp observed with fMRI of working memory (19 CBTp + TAU 
patients, 14 TAU-alone patients, and 15 healthy participants com-
mon to both investigations) and was included in a larger cross-
sectional, fMRI study of verbal monitoring (Kumari et al., 2008). 
Neither of these published reports investigated neural predictors 
of CBTp within the verbal monitoring neural network.
All participants were right-handed and had no history of neu-
rological conditions or head injury. All included patients (i) had 
been on stable doses of antipsychotics for ≥2 years, and on their 
present antipsychotic therapy for >3 months, (ii) received a rating 
of ≥60 on the Positive and Negative Syndrome scale (PANSS) (Kay 
et al., 1987) and had at least one persistent positive symptom (a 
score of 3 or above on at least one of the positive symptoms items 
of the PANSS, which they experienced as distressing), and (iii) 
wished to receive 6–8 months of CBTp in addition to their usual 
drug treatment. Patients in both the CBTp + TAU and TAU-alone 
groups were recruited from the same geographical area and had 
been identifi ed by their treating psychiatrists as suitable for CBTp. 
With the resources available at the time of this investigation to the 
South London and Maudsley (SLAM) NHS Foundation Trust, only 
about 10% of eligible patients were offered CBTp. The patients 
who were referred to and accepted for CBTp by the Psychological 
Interventions Clinic for Outpatients with Psychosis (PICuP), SLAM 
NHS Foundation Trust, constitute the CBTp + TAU group. The 
researchers did not have any say in which of the patients receive 
CBTp at this specialist clinic. There were no explicit biases in which 
patients received CBTp. This was driven by resource limitations of 
the NHS Trust. Others, matched to those in the CBTp + TAU group 
as much as possible, were allocated to the TAU-alone group. The 
fi nal CBTp + TAU group had 20 patients, and the TAU-alone group 
had 18 patients (Table 1); these patients had remained on the same 
type and dosage of antipsychotic medication during the follow-up 
period. The main reasons for patient drop outs/exclusion from the 
study were consent withdrawal, medication change or non-compli-
ance and/or acute illness exacerbation prior to follow-up.
All participants underwent fMRI during a verbal monitoring 
task and clinical assessment at entry. The CBTp + TAU group 
then received 6–8 months of CBTp following a published manual 
(Fowler et al., 1995) in a specialist clinical service (PICuP, South 
London and Maudsley NHS Foundation Trust). CBTp interven-
tions were formulation-driven and aimed to reduce distress aris-
ing from psychotic symptoms, reduce depression, anxiety and 
hopelessness, and modify dysfunctional schemas when appropri-
ate. The focus was on the therapy goals of the patient. Therapy 
sessions were conducted weekly or fortnightly, as preferred by 
the patient, and lasted for up to 1 h. Patients received an average 
of 16 sessions. The therapists were qualifi ed CBT practitioners 
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Table 1 | Demographics, clinical characteristics, and task performance of participants.
Demographic and Clinical 
Patients
 Healthy participants
Characteristics  (n = 20; 14 men)
 CBTp + TAU Group TAU-alone Group 
 (n = 20, 15 men) (n = 18, 15 men)
 Mean (SD) Mean (SD) Mean (SD)
Age (years)  35.10 (7.59) 40.44 (10.07) 33.95 (10.37)
Education (years) 13.65 (3.31) 13.33 (1.50) 15.70 (2.74)
Predicted IQa 109.73 (10.00) 105.26 (9.23) 115.70 (8.10)*
Duration of illnessb 10.74 (8.06) 15.71 (12.21) n/a
Chlorpromazine equivalents (mg) 507.00 (409.73) 459.28 (320.34) 
Antipsychotic medication 18 on atypical; 2 on 16 on atypical; 2 on 
 atypical and typical atypical and typical
TASK PERFORMANCE
% Correct Answers
 Self-undistorted 87.50 (16.60) 78.82 (23.20) 92.81 (6.18)
 Self-distorted 56.56 (38.34) 51.74 (35.02) 75.31 (28.50)
 Other-undistorted 58.13 (31.94) 61.11 (34.67) 85.31 (20.00)
 Other-distorted 57.19 (31.69) 45.49 (33.38) 62.19 (25.45)
% Errors
 Self-undistorted 1.87 (3.57) 3.82 (6.1) 1.87 (4.58)
 Self-distorted 31.87 (33.31) 29.27 (31.06) 16.25 (22.43)
 Other-undistorted 34.69 (31.31) 25.00 (28.11) 10.62 (14.06)
 Other-distorted 30.31 (31.17) 35.76 (32.99) 20.94 (31.17)
% Unsure Responses
 Self-undistorted 4.69 (14.03) 7.90 (17.12) 0.31 (1.40)
 Self-distorted 8.75 (13.51) 16.31 (18.82) 6.87 (15.16)
 Other-undistorted 6.25 (9.08) 11.11 (16.40) 3.75 (9.81)
 Other-distorted 10.62 (17.80) 15.97 (21.14) 15.00 (21.11)
% No Responses
 Self-undistorted 5.93 (4.74) 9.37 (11.59) 5.00 (3.84)
 Self-distorted 2.81 (4.74) 2.78 (4.40) 1.56 (4.91)
 Other-undistorted  0.94 (3.06) 2.43 (5.31) 0.31 (1.40)
 Other-distorted 1.87 (7.05) 2.78 (3.85) 1.87 (3.57)
aNational Adult Reading Test (Nelson and Willison, 1991); bDuration of illness = current age minus age of illness onset; *n = 19 (missing IQ data in one healthy 
participant).
and supervised by one of the two investigators (EK, ERP) who 
have extensive experience of CBTp. The treatment adherence was 
recorded via fortnightly supervision. In addition, a small, random 
selection of therapy sessions (n = 13) were taped and sent to an 
independent, experienced CBTp therapist to be rated for fi del-
ity of treatment using the Cognitive Therapy Scale for Psychosis 
(Haddock et al., 2001). The mean rating was 40.7 (range 21–53) 
out of a maximum of 60, with 77% of the tapes scoring above 
the 50% mark (i.e. >30). TAU provided to all patients prior to, 
and during, the study consisted of management offered by a case 
management team with a dedicated care-coordinator who saw 
the patient on a regular basis, in addition to a psychiatrist and 
other specialists, such as benefi ts adviser and vocational specialist, 
as needed. TAU-alone patients were followed up over the same 
period as CBTp + TAU patients in order to confi rm CBTp led, 
rather than non-specifi c (e.g. time effect), symptom improvement 
in the CBTp + TAU group.
Symptoms were rated in all patients, using the PANSS (Kay 
et al., 1987), at entry and then 6–8 months later by an independ-
ent and experienced psychiatrist (DF) who was blind to whether 
or not a patient received CBTp in addition to their usual treat-
ment. This psychiatrist had no role in recruitment and clinical 
management of any of the patients included in this investigation. 
Appointments for these assessments were made by another member 
of the research team.
The study procedures were approved by the joint research eth-
ics committee of the SLAM NHS Foundation Trust and Institute 
of Psychiatry. After complete description of the study, written 
informed consent was obtained from all participants.
fMRI TASK AND PROCEDURE
A modifi ed version (Kumari et al., 2008) of a previously described 
verbal monitoring task (Fu et al., 2006) was used. Participants 
were presented with single words visually on a computer screen 
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 (presentation time 750 ms; inter-stimulus interval 16.25 s), viewed 
via a prismatic mirror fi tted in the radiofrequency head coil, as 
they lay in the scanner and instructed to read each word aloud. 
The participant’s speech was transformed through a software pro-
gram and a DSP.FX digital effects processor (Power Technology, 
California, USA), amplifi ed by a computer sound card, and relayed 
back through an acoustic MRI sound system (Ward Ray-Premis, 
Hampton Court, UK) and pneumatic tubes within the ear protec-
tors at a volume of 91 dB (SD 2). The volume of the feedback was 
calibrated to overcome the bone conduction of the participant’s 
own voice. The verbal feedback was either: (a) their own voice (self-
undistorted); (b) their own voice lowered in pitch by 4 semitones 
(self-distorted); (c) voice of another person matched to the partici-
pant’s sex (other-undistorted); or (d) another person’s voice with 
the pitch lowered by 4 semitones (other-distorted). Participants 
were required to register their responses regarding the origin of 
feedback by pressing the appropriate button on the button box 
provided to them using their right hand. They were instructed to 
press the ‘self ’ button if they thought that the feedback was their 
own voice, the ‘other’ button if it belonged to someone else, or 
the ‘unsure’ button if they were uncertain about the nature of the 
feedback. On the computer screen below the words, three pos-
sible responses were written as ‘self ’, ‘other’ and ‘unsure’ and were 
highlighted via a black outline every time a participant registered 
his/her response by pressing one of them. Accuracy of the responses 
was recorded online, with failures to press a response button coded 
as non-responses. In total, 64 words were presented (16 words per 
task condition, presented in a pseudo-random order).
Participants were requested to abstain from alcohol for at least 
24 h prior to their scheduled scanning and underwent task famil-
iarisation to familiarize them with the procedures prior to going 
in the scanner.
IMAGE ACQUISITION
Echoplanar MR brain images were acquired using a 1.5 T GE Signa 
system (General Electric, Milwaukee WI, USA) at the Maudsley 
Hospital, London. A quadrature birdcage head coil was used for 
RF transmission and reception. In each of 14 near axial non-con-
tiguous planes (slice thickness = 7.0 mm, interslice gap = 1 mm) 
parallel to the inter-commissural (ac–pc) plane, T2*-weighted MR 
images depicting blood oxygenation level–dependent (BOLD) con-
trast were acquired over 1.1 s using a ‘clustered’ acquisition (12–14) 
(TE = 40 ms, 70° fl ip angle), which created a relative silent period of 
2.15 s for each stimulus within a TR of 3.25 s of the inter- stimulus 
interval of 16.25 s. Five brain volumes were acquired for each trial 
(TR = 3.25 s), and a stimulus, as stated earlier, was presented every 
16.25 s. A clustered acquisition sequence was used to reduce arte-
facts associated with overt speech during image acquisition (Fu 
et al., 2006). Foam padding within the head coil and a forehead 
strap were used to restrict head motion.
DATA ANALYSIS
Demographic, clinical and behavioural measures
CBTp + TAU versus TAU-alone groups: baseline comparisons. 
CBTp + TAU and TAU-alone groups were compared on age, educa-
tion, predicted IQ (Nelson and Willison, 1991) and baseline PANSS 
symptoms using independent-sample t-tests. Possible group dif-
ferences in performance of CBTp + TAU and TAU-alone groups 
were examined by Group (CBTp + TAU, TAU-alone) × Source (self, 
other) × Distortion (undistorted, distorted) analysis of variance 
(ANOVA) with Group as a between-subjects factor and Source 
and Distortion as within-subjects factors, followed by post-hoc 
analyses as appropriate. Given a marked (though statistically non-
signifi cant) difference in age between the fi nal CBTp + TAU and the 
TAU-alone groups, the effects were re-examined using analysis of 
co-variance (ANCOVA) with age entered as a covariate. Results only 
from the analysis of the correct answers are presented in detail since 
there were insuffi cient data (too few trials) to allow meaningful 
fMRI analysis of other performance indices (descriptive statistics 
for all indices presented in Table 1).
Effects of CBTp: symptom change in CBTp + TAU versus TAU-
alone groups. The change in symptoms from baseline to follow-
up was examined using a Group (CBTp + TAU, TAU-alone) × Time 
(baseline, follow-up) ANOVA with Group as a between-subjects 
factor and Time as a within-subjects factor. Given the earlier 
noted difference in age between the fi nal CBTp + TAU and the 
TAU-alone groups, the effects were re-examined using analysis 
of co-variance (ANCOVA) with age entered as a covariate. A sig-
nifi cant Group × Time effect on total and sub-scale PANSS scores 
was followed up by paired t-tests separately in the CBTp + TAU 
and TAU-alone groups. Following the confi rmation of signifi cant 
clinical improvement in the CBTp + TAU group, and no signifi cant 
change in symptoms in the TAU-alone group, potential associa-
tions between baseline symptom severity and symptom change 
(absolute change = baseline minus follow-up) in the CBTp + TAU 
group were examined using Pearson’s correlations. The effects of 
CBTp were also confi rmed using ANCOVAs on symptom change 
scores co-varying for baseline symptoms. Potential associations 
between CBTp responsiveness (total PANSS scores) and baseline 
clinical and performance variables were examined using Pearson’s 
correlations.
CBTp + TAU patients (Baseline) versus healthy participants. We 
examined possible differences between the fi nal CBTp + TAU and 
healthy groups in age, education and IQ using independent-sam-
ple t-tests, and in performance using a Diagnosis (CBTp + TAU 
patients; healthy participants) × Source (self, other) × Distortion 
(undistorted, distorted) ANOVA with Diagnosis as a between-
subjects factor and Source and Distortion as within-subjects fac-
tors, followed by post-hoc analyses as appropriate. We did not 
include TAU-alone patients (who a common as expected, did 
not show symptom improvement) in this analysis because we 
wished to establish performance level in the CBTp + TAU group 
relative to the healthy comparison group prior to examining 
whether the level of activity in brain areas found to associate 
with CBTp responsiveness refl ected i.e. hyper-, hypo-, or normal 
level of activity.
All analyses were performed in SPSS (version 15). Prior to imple-
menting the above described analyses, each variable was evaluated 
for criteria of parametric analysis. Alpha level for testing signifi -
cance of effects was maintained at p < 0.05.
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fMRI
Image pre-processing. For each participant, the functional time 
series were motion corrected, transformed into stereotactic space 
(Montreal Neurological Institute, MNI), smoothed with a 10mm 
FWHM Gaussian fi lter and band pass fi ltered using statistical paramet-
ric mapping software (SPM2; http://www.fi l.ion.ucl.ac.uk/spm).
Models and statistical inferences. Data were analysed using a ran-
dom effect procedure (Friston et al., 1999). The fi rst stage identifi ed 
subject-specifi c activations associated with correct responding in 
all participants for four task conditions (self-undistorted, self-dis-
torted, other-undistorted, other-distorted) and at the levels of Source 
[self-undistorted + self-distorted versus other-undistorted + other-
 distorted] and Distortion (self-undistorted + other-undistorted 
versus self-distorted + other-distorted). Motion parameters were 
included as covariates at this stage. Next, we identifi ed task-related 
activity changes in the CBTp + TAU group using one-sampled 
t-tests (height threshold p < 0.001, cluster corrected p ≤ 0.05).
We used the same approach as in our previous study (Kumari 
et al., 2009) to examine the relationship of CBTp responsiveness 
with pre-therapy brain activity in CBTp + TAU patients. We fi rst 
computed the degree of change in symptoms independent of initial 
severity as residual change by regressing the initial PANSS (total and 
sub-scales) scores on follow-up scores as an outcome measure of 
CBTp responsiveness. We then regressed residual symptom change 
scores on task-related activity changes across the entire brain (height 
threshold p = 0.05, cluster-corrected p ≤ 0.05). For the positive asso-
ciations of a priori hypothesised regions with CBTp responsiveness, 
the following signifi cance criteria were applied to maxima voxels 
of clusters that did not survive whole-brain correction for multiple 
comparisons: (a) T value of ≥ 2.88 (corresponding to uncorrected 
voxel p < 0.005) and ≥100 contiguous voxels, and (b) survival of 
small volume correction (SVC) within a locally defi ned volume 
(10-mm radius sphere) with family-wise error corrected p ≤ 0.05. 
Next, we extracted the subject-specifi c activation values from the 
voxels showing the strongest association with CBTp responsiveness 
(reduction in total PANSS symptoms) in each activity cluster and 
explored their possible relationships with performance and baseline 
symptom scores using Pearson’s correlations (within SPSS).
Finally, we compared task-related activity changes in the 
CBTp + TAU and healthy participant groups using independent-
sample t-tests (height threshold p = 0.05, cluster corrected p ≤ 0.05) in 
order to determine whether various activity changes found to associate 
positively with CBTp responsiveness in this patient group refl ected 
(a) a hyper response (i.e. greater in the patient group than the healthy 
group), (b) a strong response within the normal range (i.e. patients 
not signifi cantly different from healthy participants), or (c) a less 
defi cient response (if, on average, this patient group showed activa-
tion defi cit relative to the healthy group). We further probed patient-
healthy group differences in these areas with a lenient approach using 
SVC within a locally defi ned volume (5 mm radius sphere around the 
voxel showing the strongest association with reduction in total PANSS 
scores) with family-wise error corrected p ≤ 0.05.
RESULTS
DEMOGRAPHIC, CLINICAL AND BEHAVIOURAL MEASURES
CBTp+TAU versus TAU-alone groups: baseline comparisons
The fi nal CBTp + TAU and TAU-alone groups were comparable 
in age, education, predicted IQ, illness duration, PANSS (total 
and subscales) symptoms and medication dose at baseline (all p 
values > 0.05). The two groups also showed comparable perform-
ance across all task conditions (F
1,36
 < 1 for all main and interactive 
effects involving Group; this remained true after co-varying for 
age). Both groups showed marginally higher accuracy during self 
than other conditions (Source: F
1,36 
= 4.19, p = 0.048), and mark-
edly higher accuracy during undistorted than distorted conditions 
(Distortion: F
1,36 
= 46.24, p < 0.001), in particular during the self-
undistorted condition relative to the other-distorted conditions 
(Source × Distortion: F
1,36 
= 4.82, p = 0.035).
Effects of CBTp: symptom change in CBTp + TAU versus TAU-alone 
groups
The CBTp + TAU group, but not the TAU-alone group, showed change 
in symptoms from baseline to follow-up (Group × Time, total PANSS 
scores: F
1,36 
= 8.59, p = 0.006; positive symptoms: F
1,36
 = 5.01, p = 0.032; 
negative symptoms: F
1,36
 = 5.75, p = 0.022; general psychopathology: 
F
1,36
 = 6.31, p = 0.017). The same pattern of effect was observed after 
we co-varied for age (p values 0.02 or higher for Group × Time inter-
action in the total PANSS scores and individual PANSS dimensions). 
Follow-up analyses revealed signifi cant reduction in blind ratings 
of symptom on all dimensions (Table 2) at follow-up in only the 
CBTp + TAU group (total PANSS scores: t
19
 = 3.73, p = 0.001; posi-
tive symptoms: t
19
 = 3.81, p = 0.001; negative symptoms: t
19
 = 2.17, 
p = 0.043; general psychopathology: t
19
 = 3.32, p = 0.004).
Table 2 | Symptoms and symptom changes in the CBTp + TAU and TAU-alone patient groups.
Symptomsa CBTp + TAU Group Mean (SD) TAU-alone Group Mean (SD)
 Baseline Follow-up Change (Baseline Baseline Follow-up Change (Baseline
   minus Follow-up)   minus Follow-up)
Positive 18.25 (4.99) d14.90 (4.30) c3.35 (3.94) 18.72 (3.12) 18.28 (3.56) 0.44 (4.06)
Negative 17.40 (4.11) d15.50 (4.14) c1.90 (3.92) 19.06 (3.95) 20.33 (4.55) −1.28 (4.25)
General Psychopathology 34.10 (7.28) d28.55 (7.61) c5.55 (7.47) 34.56 (4.72) 34.72 (6.83) −0.17 (6.45)
Total 69.75 (13.89) d58.95 (15.07) c10.8 (12.96) 72.33 (9.22) 73.33 (12.58) −1.00 (11.72)
aPositive and Negative Symptom Scale (Kay et al., 1987); dLower symptom scores (p < 0.05) at follow-up in the CBTp + TAU, but not in the TAU-alone, group; 
cSymptom reduction (p < 0.05) in the CBTp + TAU, relative to the TAU-alone, group.
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CBTp responsiveness (total PANSS symptoms) did not sig-
nifi cantly associate with baseline symptom severity (r = 0.37, 
p = 0.107). Symptom improvement (absolute change score) in 
the CBTp + TAU group remained signifi cant after co-varying for 
baseline symptoms, relative to the TAU-alone group (total PANSS 
scores: F
1,35
 = 10.85, p = 0.002; positive symptoms: F
1,35
 = 7.94, 
p = 0.008; negative symptoms: F
1,35
 = 9.85, p = 0.003; general psy-
chopathology: F
1,35
 = 7.84, p = 0.008). As can be expected from the 
independence of symptom improvement from baseline symptoms 
in CBTp + TAU patients, residual symptom change scores (used in 
fMRI analysis) correlated highly positively with the absolute symp-
tom change scores (total PANSS symptoms: r = 0.914, p < 0.001). 
Within the CBTp + TAU group, illness duration (current age minus 
age at onset), education, NART IQ, antipsychotic medication dose 
(in chlorpromazine equivalents) and task performance (total % 
correct) were not signifi cantly associated with CBTp responsive-
ness (p values > 0.05).
CBTp+TAU patients (Baseline) versus healthy participants
The fi nal CBTp + TAU and healthy participant groups were 
comparable in age, but the CBTp + TAU group had marginally 
lower NART IQ (t
37
 = 2.04, p = 0.05) and fewer years in education 
(t
37
 = 2.73, p = 0.04) (Table 1). The patient group showed lower 
performance accuracy than healthy participants as indicated by a 
highly signifi cant main effect of Group (F
1,38
 = 11.78, p = 0.001). In 
addition, there were main effects of Source (F
1,38
 = 5.33, p = 0.03; 
indicating higher accuracy for self than other conditions) and 
Distortion (F
1,38
 = 54.82, p < 0.001; indicating higher accuracy for 
undistorted than distorted conditions), and a marginally signifi cant 
Diagnosis × Source × Distortion interaction (F
1,38
 = 4.08, p = 0.05). 
Further analysis of this interaction revealed that healthy participants 
were signifi cantly better than CBTp + TAU patients at identifying 
other-undistorted voices (t
38
 = 3.23, p = 0.003). There was a trend 
for better recognition of self-distorted voices in the healthy group 
compared to the CBTp + TAU group (t
38
 = 1.76, p = 0.087). The two 
groups did not differ signifi cantly in identifying self-undistorted 
or other-distorted voices (p > 0.10), although accuracy was some-
what lower in the patient group across all task conditions (Table 1). 
NART IQ or years in education did not correlate signifi cantly with 
performance (total % correct) in the CBTp + TAU group or the 
healthy group (p values > 0.10).
fMRI
Generic activity changes in CBTp+TAU patients
The generic verbal monitoring network identifi ed revealed strongly 
overlapping activation and deactivation patterns for the four task 
conditions. This network included bilateral activations in the 
IFG, superior temporal gyrus, putamen, precuneus and thalamus 
(Table 3, Figure 1). The regions deactivated across all conditions 
included the middle-posterior cingulate, angular and parahippoc-
ampal gyri (Table 3, Figure 1).
fMRI predictors of CBTp responsiveness
The expected association between pre-therapy left IFG activa-
tion [Brodmann area (BA) 44–45–47] and CBTp responsiveness 
was found for all three PANSS symptom dimensions. This effect 
was more strongly and consistently present during monitoring of 
own undistorted speech than someone else’s/own distorted speech 
(Table 4, Figure 2), and meant that those with a marked benefi cial 
response to CBTp showed stronger activation of this area.
The IFG association clusters extended to the medial prefrontal 
cortex (BA10–BA32; located somewhat anterior and dorsal to the 
area deactivated across all participants) during the undistorted 
conditions, and were also present as higher medial prefrontal 
activity during undistorted compared to distorted feedback 
conditions. Further probing revealed that patients with the 
most benefi cial response to CBTp did not show deactivation or 
showed some activation (mainly self) during the undistorted 
conditions, and showed deactivation of this region during the 
distorted conditions.
CBTp responsiveness also associated positively with (a) less 
deactivation/slight activation of the inferior parietal lobe (prima-
rily BA 40 and BA7) during accurate monitoring of own, relative 
to someone else’s, speech regardless of the level of distortion, and 
(b) more thalamic and precuneus activation to distorted speech 
relative to undistorted speech, regardless of the source (Table 4, 
Figure 2).
It is important to note that brain activity-CBTp response asso-
ciations found in this study were present in both male and female 
patients (illustrated in Figure 3 with the left IGF-CBTp response 
association). Interestingly, pre-therapy fMRI activity and CBTp 
responsiveness associations were not signifi cantly present for the 
other-distorted condition when this was examined as an individual 
task condition, perhaps because of the lowest power available (i.e. 
lowest number of correct answers thus less volume of fMRI data) 
during this condition. At the level of symptom improvement, nega-
tive symptoms dimension had the least power (smallest change 
with CBTp). Baseline symptoms or performance accuracy did 
not correlate signifi cantly with CBTp response predictive brain 
regions, although a small positive association (r = 0.34, p = 0.14) 
was present for the left IFG activation and accuracy during the 
self-undistorted condition.
CBTp+TAU versus healthy participants
CBTp + TAU patients showed signifi cantly reduced activations, 
compared to healthy participants, in a number of regions during 
the distorted conditions, including the putamen, anterior cingulate 
and thalamus during the self-distorted and the left IFG during 
the other-distorted conditions (Table 5). Patients were also dif-
ferentiated from healthy participants by reduced deactivation of 
parahippocampal and posterior cingulate gyri, and altered medial 
prefrontal cortex and caudate activity modulation between the self 
and other conditions.
When differences between the CBTp + TAU group and the 
healthy group in activations and deactivations of regions associ-
ated with CBTp responsiveness (in the CBTp + TAU group) were 
examined with a lenient approach (SVC), CBTp + TAU patients, 
relative to healthy participants, showed less activation of the left 
IFG (x = −36, y = 50, z = −2; voxel T = 2.38, uncorrected p = 0.009, 
SVC-corrected p = 0.05). There was a trend for this effect in the tha-
lamus (x = 6, y = −22, z = −8; voxel T = 2.41, uncorrected p = 0.01, 
SVC-corrected p = 0.07).
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Table 3 | Brain areas showing signifi cant change in task-related activity in CBTp + TAU patients (voxel threshold p = 0.001; cluster p corrected for 
multiple comparisons).
Brain region Cluster size BA Side MNI Voxel Cluster
 (voxels)   coordinates T value p value
    X Y Z  
ACTIVITY INCREASES
Self-undistorted
 Superior temporal gyrus 2597 22 L −52 −50 14 10.72 <0.001
  42/22 L −50 −34 16 8.01 
  42 L −62 −28 6 7.55 
 Thalamus 568 N/a R 10 −18 4 7.74 <0.001
  N/a L −12 −16 8 5.75 
 Brain stem  N/a L −8 −28 −6 5.25 
 Superior temporal gyrus 3128 22 R 50 −32 18 6.76 <0.001
 (extends to the inferior  22 R 60 −4 8 6.76
 frontal gyrus and insula)   22 R 56 −20 4 6.23
 Cuneus 469 18 R 12 −66 14 6.14 0.005
  18 R 12 −78 18 5.42 
 Lingual gyrus  19 R 20 −64 −2 4.18 
 Precuneus 270 18 L −16 −76 24 4.80 0.038
 Cuneus  18 L −26 −82 24 3.80 
Self-distorted
 Superior temporal gyrus 2483 42 L −60 −24 16 11.54 <0.001
  22 L −58 −36 14 9.09 
  42 L −62 −16 10 8.72 
 Superior temporal gyrus 3425 22 R 60 −10 2 11.38 <0.001
 (extends to the inferior  22 R 56 −24 0 9.79
 frontal gyrus and insula)
 Precentral gyrus  6 R 54 −6 32 6.60 
 Precuneus 656 7 L −18 −76 42 6.71 <0.001
 Cuneus  19 L −18 −90 26 4.92 
  19 L −20 −82 32 4.48 
 Precentral gyrus 180 6 L −44 −14 38 5.16 0.047
Other-undistorted
 Thalamus 827 N/a R 10 −22 4 9.60 <0.001
  N/a L −6 −20 4 6.83 
  N/a R 8 −28 −4 5.87 
 Superior temporal gyrus 4108 22 L −50 −30 12 9.36 <0.001
  42 L −54 −22 14 8.59 
 Inferior frontal gyrus  47 L −40 22 −6 6.70 
 Superior temporal gyrus 2650 22 R 54 −22 −2 8.68 <0.001
 Precentral gyrus  6 R 64 −2 22 8.16 
 Middle temporal gyrus  21 R 60 −32 0 7.30 
 Cuneus 283 17 R 16 −68 8 5.08 0.018
  18 R 14 −78 16 4.81 
 Lingual gyrus  18 R 14 −82 −2 4.59 
Other-distorted
 Thalamus 645 N/a R 12 −16 4 7.94 0.001
  N/a L −10 −22 6 7.59 
 Brain stem  N/a R 10 −28 −2 5.56 
 Superior temporal gyrus 2490 42 L −52 −24 12 7.93 <0.001
 Precentral gyrus  4/6 L −52 −14 42 6.24 
 Superior temporal gyrus  22 L −54 −40 18 6.15 
Continued
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Table 3 | (Continued).
Brain region Cluster size BA Side MNI Voxel Cluster
 (voxels)   coordinates T value P value
    X Y Z  
Superior temporal gyrus 1856 22 R 60 −10 0 6.87 <0.001
  22 R 60 −2 14 6.25 
Precentral gyrus  6 R 52 −10 38 6.25 
ACTIVITY DECREASES
Self-undistorted
 Posterior cingulate 412 30 L −22 −38 12 5.87 0.009
  29 L −18 −28 18 5.17 
 Parahippocampal gyrus  30 L −28 −50 −2 4.36 
 Medial prefrontal gyrus 342 9 L −4 48 26 5.83 0.017
 (extends to the caudate)
 Parahippocampal 299 30 R 28 −44 6 5.12 0.027
 gyrus/posterior cingulate
 Posterior cingulate  29 R 24 −36 12 4.51 
  29 R 18 −30 18 4.37 
 Anterior cingulate  32 L −2 42 6 4.98 <0.001
  24 R 2 36 0 4.82 
Self-distorted
 Angular gyrus 317 39 R 46 −64 38 5.29 0.005
 Supramarginal gyrus  40 R 54 −54 46 4.81 
 Anterior cingulate 1114 24 L −12 30 6 4.91 <0.001
  23/32 – 0 44 2 4.84 
  24 R 20 30 −6 4.81 
 Posterior cingulate 528 29 L −22 −46 18 4.85 <0.001
 Parahippocampal gyrus  18 L −32 −48 2 4.77 
 Middle temporal lobe  39 L −26 −52 8 4.54 
Other-undistorted
 Angular gyrus 2997 39 L −44 −72 34 11.81 <0.001
 Posterior cingulate  31 L −10 −62 26 8.12 
  29 L −26 −48 6 6.04 
 Anterior cingulate 636 24 L −8 24 16 5.27 <0.001
  24 – 0 34 4 4.62 
Other-distorted
 Angular gyrus 464 40 L −42 −64 34 6.76 0.004
 Inferior parietal lobe 508 40 R 50 −58 44 5.94 0.002
 Angular gyrus  39/40 R 46 −66 34 5.60 
SOURCE: SELF > OTHER    NONE
Source: other > self
 Caudate 193 N/a L −6 4 6 6.01 0.024
  N/a R 10 2 10 3.43 
Distortion: distorted < undistorted    none
Distortion: undistorted < distorted    none
Brodmann Area=BA; L=left; R=Right; self-undistorted n = 20; Self-distorted n = 17; Other-undistorted n = 18; Other-distorted n = 18; Self vs. Other and Undistorted 
vs. Distorted n = 15 (n reduced due to no correct trials for few participants during a particular condition).
DISCUSSION
This investigation focussed on the association between responsive-
ness to 6–8 months of CBTp and pre-therapy brain activity during 
monitoring of self- and externally-generated speech in people with 
schizophrenia. It also examined a representative group of healthy 
participants to characterise this patient sample.
Clinically, confi rming our observations in an overlapping sam-
ple (Kumari et al., 2009) and fi ndings of recent meta analyses of 
RCTs for CBTp (Pilling et al., 2002; Zimmermann et al., 2005; 
Pfammatter et al., 2006; Wykes et al., 2008; NICE, 2009) we found 
reduced symptom severity, on average, in patients who received 
6–8 months of CBTp adjunct to their usual treatment compared 
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FIGURE 1 | Group activation maps showing regions with signifi cant task-
related activity changes in CBTp + TAU patients in the sagittal, coronal 
and axial “look through” views (maps thresholded at ρ = 0.001 
uncorrected; all displayed clusters signifi cant at p < 0.05 after correction 
for multiple comparisons). Left hemisphere is shown on the left of the 
axial view.
to the patient group who continued with their usual treatment. 
Also consistent with data from previous studies was our fi nding 
of considerable variation in the degree of symptom change for 
individual patients, with the change in total PANSS scores from 
baseline to follow-up ranging from 8 (slight worsening) to −42 
(strong improvement) (Figure 3, x axis).
At the neural level, as hypothesized, activation of the left IFG 
associated with a benefi cial response to CBTp on all PANSS symp-
tom dimensions (Table 4). This association was present more 
consistently during monitoring of own undistorted speech than 
someone else’s or own distorted speech. This may at least in part 
be due to the fact that this condition, with the highest number of 
correct trials, had the maximum power to detect expected rela-
tionships. The observed left IGF-CBTp response association lends 
support to earlier fi ndings of Bruder and colleagues (Bruder et al., 
1997) concerning CBT for depression and can be attributed to the 
role of the left IFG (Broca’s area) in speech and language process-
ing (Demonet et al., 2005). The left IFG also contributes to verbal 
working memory (Cabeza and Nyberg, 2000; Wager and Smith, 
2003) which was a likely component of performance on the task 
used in this study (i.e. remembering the feedback while making a 
decision about its origin). Given that CBTp + TAU patients also 
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Table 4 | fMRI activity showing positive associations with CBTp responsiveness in patients (voxel threshold p = 0.05).
Brain region Cluster BA Side MNI Voxel p value
 size (voxels)   coordinates T (corrected)
    X Y Z  
POSITIVE SYMPTOMS
Self-undistorted
 Medial prefrontal gyrus 3195 10 R 12 54 16 3.46 0.047
  10 L −10 58 18 3.29 
 Inferior frontal gyrus  45/46 L −36 34 8 3.15 
Other-undistorted
 Medial prefrontal gyrus 5250 10/32 R 22 42 16 4.11 0.013
 Inferior frontal gyrus  45 L −36 32 4 3.58 
  45 L −36 24 22 3.41 
Undistorted > distorted
 Medial frontal gyrus/ 4833 10/32 R 8 48 −6 4.61 0.009
 Anterior cingulate gyrus  10/32 L −6 58 22 4.03 
 Inferior frontal gyrus  45/46 R 44 44 8 3.75 
NEGATIVE SYMPTOMS
Self-undistorted
 Inferior-middle frontal gyrus 3799 47/10 L −36 50 2 5.00 0.004
 Medial prefrontal gyrus  10 R 2 58 14 3.92 
  10 L −6 60 16 3.21 
Other-undistorted
 Medial prefrontal gyrus 1519 10 R 14 54 −6 3.70 0.045
 Middle frontal gyrus  10 R 38 58 14 2.68 
  10 L −26 50 −6 2.45 
GENERAL PSYCHOPATHOLOGY
Self-undistorted
 Inferior frontal gyrus 1601 45 L −44 44 4 3.62 0.037
  45 L −38 34 6 3.56 
  47 L −36 50 −2 2.94 
Self-distorted
 Inferior parietal lobe 1174 40 R 36 −44 38 4.33 0.029
  7 R 20 −60 34 3.30 
  39 R 36 −62 26 2.79 
Self > other
 Inferior parietal lobe 1360 40 L −44 −46 24 5.44 0.008
  40 L −50 −38 34 3.81 
  7 L −20 −62 36 3.56 
 Inferior parietal lobe/ 910 40 R 34 −50 34 4.35 0.033
 supramarginal gyrus  40 R 58 −50 34 2.57 
  40 R 50 −46 32 2.00 
Undistorted > distorted
 Middle frontal gyrus 1727 10 R 42 48 4 4.66 0.020
 Medial frontal gyrus  32/10 R 6 46 −2 3.85 
  10 L −18 56 −4 3.38 
TOTAL SYMPTOMS
Self-undistorted
 Inferior frontal gyrus 3540 47 L −36 50 −2 4.00 0.02
 Medial prefrontal gyrus  10 L −8 60 14 3.58 
  10 R 4 58 14 3.56 
Continued
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Table 4 | (Continued).
Brain region Cluster BA Side MNI Voxel p value
 size (voxels)   coordinates T (corrected)
    X Y Z  
Self-distorted
 Inferior parietal lobe 4027 40 R 36 −44 36 4.15 0.022
  7 R 20 −60 34 3.87 
  40 R 36 −62 26 3.39 
 Inferior parietal lobe 1969 40/7 L −32 −58 52 4.10 0.031
  7 L −16 −72 46 3.86 
  40 L −56 −54 46 3.08 
Other-undistorted
 Medial frontal gyrus 2346 10 R 12 54 −2 3.18 0.02
  10 L −6 58 12 3.07 
 Middle frontal gyrus  10 R 36 56 18 3.04 
Self > other
 Inferior parietal lobe/ 1252 40 R 34 −50 34 4.94 0.015
 supramarginal gyrus  40 R 34 −56 26 3.88 
  40 R 54 −52 34 2.57 
 Inferior parietal lobe 1652 40 L −44 −46 28 3.57 0.018
  7 L −24 −64 34 3.19 
 Inferior frontal gyrus 1313 44 L −48 16 34 3.11 0.036
  44 L −48 12 36 3.01 
  44 L −52 18 30 2.92 
Undistorted > Distorted
 Medial frontal gyrus/ 3026 10/32 R 4 50 −4 5.05 0.01
 Anterior cingulate gyrus  10/32 R 8 64 22 3.58 
 Middle frontal gyrus  45/46 R 44 46 6 3.52 
Distorted > Undistorted
 Thalamus (pulvinar) 4021 N/a R 6 −22 8 3.87 0.025
 Calcarine sulcus  N/a R 24 −50 12 3.54 
 Precuneus  7 R 18 −42 42 3.37 
Brodmann Area=BA; L=left; R=Right. In italics: SVC criterion applied. All others: cluster p corrected for multiple comparisons across the entire brain.
displayed, on average, hypo-activation of the left IFG relative to 
healthy participants, our fi nding also suggests that normal range 
or less defi cient activation (i.e. maximum within the patient group) 
boosts CBTp response. Whether such an association is specifi c to 
CBTp or also applies to other psychological interventions that 
involve ‘talking’ remain to be clarifi ed. The lack of a signifi cant 
direct association between task performance and CBTp respon-
siveness in this investigation may be due to the fact that task per-
formance most likely included not only the ability to process and 
perceive own and someone else’s speech but, in addition, other 
functions such as prior knowledge and experience of having used 
the word stimuli facilitating recognition in self-generated voice. 
Some components of task performance may be less relevant than 
others to CBTp responsiveness.
The IFG association clusters extended to the medial prefrontal 
cortex (BA10–BA32) during the undistorted conditions, and dur-
ing undistorted compared to distorted feedback. This association 
showed that those with the maximum symptom improvement after 
CBTp mostly showed no deactivation or some activation rather 
than deactivation (self-undistorted) during the undistorted con-
ditions, and showed deactivation of this region only during the 
distorted conditions.
Brain deactivations are commonly found during cognitive tasks 
(Frith et al., 1991; Binder et al., 1999; Gusnard and Raichle, 2001; 
Mazoyer et al., 2001; McKiernan et al., 2003, 2006; Raichle and 
Snyder, 2007). These are considered to refl ect suspension of sponta-
neous thought processes, including monitoring of own body image 
and mental states, that occur during the rest state (default mode 
of brain function) while study participants are required to focus 
on specifi c external task demands (Binder et al., 1999; Gusnard 
and Raichle, 2001; Mazoyer et al., 2001; McKiernan et al., 2006). 
Although deactivations across most cognitive tasks include regions 
such as the posterior cingulate gyrus, dorsomedial prefrontal cortex, 
rostral cingulate gyrus and the angular gyrus (Binder et al., 1999; 
Mazoyer et al., 2001; McKiernan et al., 2003; Raichle and Snyder, 
2007), the diffi cultly level and characteristics of the task are impor-
tant determinants of the exact pattern and the extent of deactiva-
tions (McKiernan et al., 2003, 2006). More diffi cult levels of the 
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FIGURE 2 | Pre-therapy brain activity associated positively with a response to CBTp (reduction in total PANSS symptoms) in patients with associated MNI 
z co-ordinates (maps thresholded at p = 0.05 uncorrected). Left hemisphere is shown on the left.
















FIGURE 3 | Scatter plot of left inferior frontal gyrus activity during the 
self-undistorted condition against the change in symptoms in 
CBTp + TAU patients classifi ed by sex.
task produce larger deactivations than the easier ones (McKiernan 
et al., 2006), with further infl uence of diffi culty in different domains 
(e.g. stimulus discriminability, working memory load) (McKiernan 
et al., 2003). It is obvious from our task performance that the dis-
torted conditions were more diffi cult than undistorted conditions 
(markedly lower accuracy during the distorted relative to undis-
torted conditions). fMRI fi ndings show that those failing to gain 
from CBTp showed maximum deactivation during the conditions 
of undistorted feedback (i.e. relatively easier conditions), and failed 
to show expected stronger deactivations with the distorted feedback 
conditions. Those showing a strong benefi cial response to CBTp 
on the other hand showed marked deactivations only with the 
distorted conditions (i.e. the normal parametric modulation of 
deactivations) and showed slight (non-signifi cant) activation dur-
ing the self-undistorted condition. The latter observation is likely 
to be related to the processes shared by both the brain’s default 
mode of function and the requirement of this task condition, i.e. 
self-monitoring (Gusnard et al., 2001; Raichle et al., 2001).
CBTp responsiveness also associated positively with less bilat-
eral deactivation of the inferior parietal lobe (BA39–BA40–BA7) 
during accurate monitoring of own, relative to someone else’s, 
voice, regardless of the level of distortion. As discussed previously 
(Kumari et al., 2008), there is likely to be some overlap between 
the ‘self ’ conditions, which involved processing of own familiar 
voice, and the default baseline state (shown by the healthy group 
and in patients who responded well to CBTp). The fi ndings suggest 
that patients benefi ting most from CBTp processed self-relevant 
information more effi ciently and displayed a greater default mode 
differentiation of own and others’ speech.
The right parietal lobe is considered ‘responsible for maintaining 
a self-other distinction across a variety of sensory modalities’ (Uddin 
et al., 2005). This fi ts with the propositions of Shad and colleagues 
(Shad et al., 2007) that right inferior parietal lobe defi cit contributes 
to anosognosia (unawareness of symptoms) via poor self-monitor-
ing in schizophrenia. This is pertinent because cognitive insight has 
emerged as a mediator of response to CBT in psychotic disorders 
(Granholm et al., 2006). Cognitive insight in schizophrenia focuses 
on some of the cognitive processes (distancing, objectivity, perspec-
tive, and self-correction) involved in patients’ re-evaluation of their 
anomalous experiences and re-interpretation of their beliefs (Beck 
et al., 2004) whereas clinical measurements of insight (termed ‘clini-
cal insight’ by Beck and colleagues) have traditionally focused on 
patients’ unawareness of having a mental disorder and their need for 
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treatment, usually focussed on their need for medication. Cognitive 
and clinical insight measures are reported to be moderately corre-
lated in psychotic individuals (Pedrelli et al., 2004). Although the 
neural substrates of cognitive insight in schizophrenia have yet not 
been investigated, they may at least partially overlap with those areas 
reported or proposed for clinical insight (Shad et al., 2007) and also 
involve the right parietal lobe. It should, however, be noted that 
CBTp response in our study was associated with activity changes in 
both the left and the right inferior parietal lobes. While a strong case 
has already been made by previous researchers for the right parietal 
lobe involvement in self-monitoring and insight in schizophrenia 
(Shad et al., 2007), our ability to infer someone else’s perspective is 
reported to depend on functions of the left temporo-parietal junc-
tion (Samson et al., 2004, 2005). It is conceivable that CBTp (and 
good cognitive insight) would be facilitated when a patient is able 
to infer someone else’s (e.g. therapist’s) perspective and generate an 
alternative perspective to interpret his/her abnormal experiences.
Greater thalamic and precuneus activation to distorted, relative 
to undistorted, speech regardless of the source (self, other) also 
associated with a greater response to CBTp.
Stronger activation of the thalamus during distorted versus 
undistorted feedback might indicate increased attention to dis-
torted (more diffi cult) speech stimuli (Adler et al., 2001) in CBTp 
responders. Given that CBTp + TAU patients also displayed, on 
average, a trend for thalamic hypo-activation relative to healthy 
participants, this fi nding may suggest greater CBTp led benefi ts 
in those with relatively normal thalamic activation or a smaller 
activation defi cit. In healthy volunteers, precuneus activation has 
been found in association with awareness of the self (Andreasen 
et al., 1995), comparing self to non-self representations (Kircher 
et al., 2000, 2002), and refl ecting about own personality traits and 
physical appearance (Kjaer et al., 2002). In patients with schizo-
phrenia, larger precuneus volume is associated with good insight, 
especially the awareness of problems (Cooke et al., 2008). Increased 
precuneus activation during distorted conditions thus could be 
associated with CBTpP responsiveness via increased awareness of 
own mental states.
It is important to highlight that activity changes found to be 
associated with CBTp responsiveness in this study are different 
to those that were associated with specifi c symptom profi les (i.e. 
Table 5 | Brain areas differentiating the healthy and CBTp + TAU groups (voxel threshold p = 0.05, cluster p corrected for multiple comparisons).
Brain Region Cluster BA Side MNI Voxel Cluster Direction
 size (voxels)   Coordinates T p of effect
    x y z   
SELF-UNDISTORTED
No signifi cant difference between healthy participants and patients
SELF-DISTORTED
Putamen 8019 n/a R 16 0 6 3.02 0.002 Greater activation in healthy
Anterior cingulate  24/9 L −4 36 26 2.90  participants relative to patients
Thalamus (pulvinar)  n/a R 30 −26 6 2.87  
OTHER-UNDISTORTED
No signifi cant difference between healthy participants and patients
OTHER-DISTORTED
Inferior frontal gyrus 10760 47 L −42 16 −6 5.31 <0.001 Greater activation in healthy
Superior temporal gyrus  48 L −48 10 −14 4.92  participants relative to patients
Hippocampus  n/a R 30 −8 −18 3.94  
Parahippocampal gyrus 5051 n/a L −32 −38 −6 3.82 0.023 Less deactivation in patients
Posterior cingulate gyrus  29 L −14 −36 10 3.71  relative to healthy participants
Lingual gyrus  19 R 16 −66 0 3.10  
SOURCE: SELF VS. OTHER
Medial frontal gyrus 4459 10 R 20 50 2 3.24 0.018 Greater medial prefrontal
         gyrus deactivation during
         other, relative to self in healthy
         participants; opposite effect
         in patients
Caudate nucleus  n/a L −8 10 4 3.21  Caudate deactivation to self,
  n/a R 14 2 10 3.15  and slight activation to other,
         conditions in patients but not
         in healthy participants
    
DISTORTION: UNDISTORTED VS. DISTORTED
No signifi cant difference between healthy participants and patients
Brodmann Area = BA; L= left; R = Right.
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exaggerated middle-superior temporal activations with positive 
symptoms, ventral striatal and hypothalamic activity alterations 
with negative symptoms) in our earlier study (Kumari et al., 2008), 
which included patients from this study.
This investigation had limitations. Firstly, it did not use a ran-
dom design, due to resource limitations, for allocation of patients 
to CBTp + TAU and TAU-alone groups. The patients, however, 
were randomly distributed across the two groups in terms of their 
desire to receive CBTp. Furthermore, the aim of this study was to 
investigate neural predictors of CBTp in patients who undergo 
this therapy (in addition to their usual treatment) and the pri-
mary analyses to achieve this aim utilized the data obtained only 
in the CBTp + TAU group. Secondly, the fi nal CBTp + TAU and 
TAU-alone groups differed slightly (non-signifi cantly) in age and 
illness duration. This happened because of unbalanced drop outs 
in the two patient groups and was beyond our control. It however 
may not affect our results in terms of neural predictors since age 
or illness duration was not a signifi cant predictor of CBT response 
in our sample. Thirdly, it can be argued that CBTp + TAU patients 
showed symptom improvement simply because of therapist con-
tact, independent of the specifi c effects of the CBT methods applied 
to them. This is, however, unlikely. A large number of RCTs have 
shown that CBTp has specifi c effects on symptoms, as opposed to 
other psychological interventions such as family therapy (decreases 
relapse and hospitalization rates), social skill training (helps acquire 
social skills) or cognitive remediation therapy (improves cognitive 
functioning) (Zimmermann et al., 2005; Pfammatter et al., 2006; 
Wykes et al., 2008), and is superior in reducing the symptoms to a 
non-specifi c befriending intervention controlling for the amount 
of contact with treating professionals (Sensky et al., 2000). Finally, 
given that some regions found to be associated with CBTp respon-
siveness did not show robust task-related activity changes at the 
group level (though present when examined at a relatively lenient 
threshold; data not shown), further studies using tasks which more 
robustly activate these brain regions (for example, for the left IFG, 
the use of a verbal fl uency paradigm requiring generation of words 
as opposed to the current paradigm which required participants 
to only read the words that were presented to them on the screen) 
are needed to confi rm our fi ndings.
CONCLUSIONS
The fi ndings demonstrate positive associations between CBTp 
responsiveness in schizophrenia and greater left IFG activity during 
accurate monitoring, especially of own voice, less inferior parietal 
deactivation/slight activation with own, relative to someone else’s, 
voice, and less medial prefrontal deactivation and greater thalamic 
and precuneus activation with monitoring of distorted, relative to 
undistorted, voices. Given the known functions of these regions 
in humans, the fi ndings implicate language processing (left IFG), 
attention (thalamus), and insight and self-awareness (medial pre-
frontal, inferior parietal, precuneus) in responsiveness to CBTp in 
schizophrenia, and suggest avenues for future development/modi-
fi cation of CBTp for patients who appear relatively less responsive 
to current versions of the routine CBTp. Targeting insight and 
self-monitoring skills very early during the course of CBTp may 
help to improve response rates. CBTp may also need to be modu-
lated further for patients with impaired language processing skills. 
Clinically, given scarce resources, it may be helpful to prioritise 
those with good working memory and unimpaired language skills, 
when offering CBTp.
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